Get the Stockscreener App
0.052
0.00%
0.00
After Hours:
.05
-0.002
-3.85%
Hepion Pharmaceuticals Inc stock is traded at $0.052, with a volume of 45,515.
It is up +0.00% in the last 24 hours and down -8.77% over the past month.
See More
Previous Close:
$0.052
Open:
$0.0363
24h Volume:
45,515
Relative Volume:
1.35
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-13.56M
P/E Ratio:
-0.0046
EPS:
-11.31
Net Cash Flow:
$-6.30M
1W Performance:
+30.00%
1M Performance:
-8.77%
6M Performance:
-33.33%
1Y Performance:
-99.85%
1-Day Range:
$0.0363
$0.052
1-Week Range:
$0.0363
$0.052
52-Week Range:
$0.0341
$0.10
Hepion Pharmaceuticals Inc Stock (HEPA) Company Profile
Name
Hepion Pharmaceuticals Inc
Sector
Industry
Phone
-
Address
-
Compare HEPA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HEPA
Hepion Pharmaceuticals Inc
|
0.052 | 0 | 0 | -13.56M | -6.30M | -11.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.87 | 116.01B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.60 | 80.33B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
740.40 | 44.42B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
323.59 | 42.53B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
302.29 | 33.32B | 5.36B | 287.73M | 924.18M | 2.5229 |
Hepion Pharmaceuticals Inc Stock (HEPA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-20-20 | Resumed | ROTH Capital | Buy |
Hepion Pharmaceuticals Inc Stock (HEPA) Latest News
Gap Down: Should I buy Hepion Pharmaceuticals Inc. stock now2026 Earnings Impact & Daily Momentum Trading Reports - baoquankhu1.vn
Hepion Expands Liver Cancer Liquid Biopsy Theranostics Portfolio - TipRanks
Hepion Pharmaceuticals (HEPA) Enhances Early Cancer Detection wi - GuruFocus
ctRNA deal advances Hepion (OTCQB: HEPA) liquid biopsy strategy - Stock Titan
Blood test aims to spot deadly liver cancer earlier in cirrhosis - Stock Titan
HEPA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Fundamentals Check: Will Hepion Pharmaceuticals Inc benefit from rate cuts2025 Performance Recap & Consistent Growth Equity Picks - baoquankhu1.vn
Can Hepion Pharmaceuticals Inc. scale operations efficientlyEarnings Overview Report & Long-Term Investment Growth Plans - mfd.ru
How strong is Hepion Pharmaceuticals Inc. stock balance sheet2025 Trading Recap & Verified Entry Point Signals - mfd.ru
What catalysts could drive Hepion Pharmaceuticals Inc. stock higherTrend Reversal & Real-Time Stock Entry Alerts - mfd.ru
Financial Review: Virios Therapeutics (NASDAQ:VIRI) versus Hepion Pharmaceuticals (NASDAQ:HEPA) - Defense World
Analyst Calls: Can Hepion Pharmaceuticals Inc scale operations efficiently2025 Price Momentum & Verified High Yield Trade Plans - baoquankhu1.vn
Can Hepion Pharmaceuticals Inc deliver consistent EPS growthJuly 2025 Weekly Recap & Daily Entry Point Alerts - baoquankhu1.vn
Aug Setups: How volatile is IQVIA Holdings Inc stockJuly 2025 Setups & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Market Catalysts: Is SPX Technologies Inc a turnaround storyPortfolio Update Summary & Real-Time Volume Triggers - baoquankhu1.vn
Bearish Setup: Is Bright Horizons Family Solutions Inc stock technically oversoldWeekly Trend Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Will Hepion Pharmaceuticals Inc. stock see PE expansionTrend Following Strategies & Free Unlock Stock Analysis - Bollywood Helpline
Weekly Recap: Will Interactive Strength Inc be affected by tariffs2025 Analyst Calls & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Aug Fed Impact: Can Hepion Pharmaceuticals Inc be the next market leader2025 Growth vs Value & Weekly Top Gainers Alerts - baoquankhu1.vn
Hepion Pharmaceuticals appoints Dr. Kaouthar Lbiati as CEO with new employment agreement - Investing.com Canada
Hepion Pharmaceuticals appoints Dr. Kaouthar Lbiati as CEO with new employment agreement By Investing.com - Investing.com South Africa
Market Review: Why Hepion Pharmaceuticals Inc stock could see breakout soonFed Meeting & Low Risk Entry Point Tips - Bộ Nội Vụ
Why Hepion Pharmaceuticals Inc stock remains resilientEarnings Growth Report & Real-Time Volume Surge Alerts - Bộ Nội Vụ
Why Hepion Pharmaceuticals Inc. (336) stock attracts wealthy investors2025 Price Targets & Risk Controlled Daily Trade Plans - ulpravda.ru
Aug Intraday: How Hepion Pharmaceuticals Inc. stock compares to growth peersJuly 2025 Trends & Weekly High Return Stock Forecasts - Улправда
Head to Head Analysis: Hepion Pharmaceuticals (NASDAQ:HEPA) versus eFFECTOR Therapeutics (NASDAQ:EFTR) - Defense World
Why Hepion Pharmaceuticals Inc. stock remains resilient2025 Performance Recap & Stepwise Trade Signal Implementation - ulpravda.ru
Is Hepion Pharmaceuticals Inc. stock a buy before product launchesMarket Performance Recap & Fast Entry and Exit Trade Plans - Улправда
Why Hepion Pharmaceuticals Inc. stock could see breakout soonGDP Growth & Stock Market Timing Techniques - ulpravda.ru
Is Hepion Pharmaceuticals Inc. (336) stock attractive post correctionInflation Watch & Smart Allocation Stock Tips - Улправда
How buybacks impact Hepion Pharmaceuticals Inc. stock valueWeekly Gains Report & Free Community Supported Trade Ideas - ulpravda.ru
Will Hepion Pharmaceuticals Inc. stock split attract more investorsQuarterly Portfolio Report & Long-Term Growth Stock Strategies - Улправда
Hepion Pharmaceuticals, Inc.Common Stock (NQ: HEPA - FinancialContent
Book value per share of Hepion Pharmaceuticals, Inc. – MUN:3360 - TradingView — Track All Markets
Price Clustering Detected in Bisil Plast Limited StockFlag and Pennant Patterns & Free Real-Time Trading Alerts Every Day - bollywoodhelpline.com
Travel Stocks: Will Hepion Pharmaceuticals Inc stock split attract more investorsEarnings Growth Summary & Stock Portfolio Risk Management - moha.gov.vn
HEPA (Hepion Pharmaceuticals) EV-to-FCF : -0.10 (As of Dec. 22, 2025) - GuruFocus
Can Hepion Pharmaceuticals Inc. (336) stock sustain breakout momentum2025 Big Picture & Fast Moving Trade Plans - Улправда
Is Hepion Pharmaceuticals Inc. stock a bargain at current levels2025 EndofYear Setup & Growth Focused Investment Plans - DonanımHaber
Will Hepion Pharmaceuticals Inc. (336) stock see insider accumulation2025 Risk Factors & Real-Time Sentiment Analysis - DonanımHaber
How Hepion Pharmaceuticals Inc. stock compares to growth peersJuly 2025 Movers & Weekly Momentum Stock Picks - DonanımHaber
What is the fair value of Hepion Pharmaceuticals Inc. stock nowPortfolio Growth Summary & Accurate Intraday Trade Tips - Улправда
Why Hepion Pharmaceuticals Inc. stock could rally in 2025Trade Exit Report & Fast Gain Swing Trade Alerts - Улправда
Growth Report: How Hepion Pharmaceuticals Inc. stock trades during market volatilityGap Up & Risk Controlled Daily Trade Plans - Улправда
Why Hepion Pharmaceuticals Inc. stock is considered a top pickRisk Management & Reliable Breakout Forecasts - Улправда
Hepion Pharmaceuticals to be delisted from Nasdaq - Investing.com Nigeria
Will Hepion Pharmaceuticals Inc. (336) stock outperform foreign stocksQuarterly Profit Report & Real-Time Volume Analysis - Newser
Why Hepion Pharmaceuticals Inc. (336) stock benefits from AI revolutionJuly 2025 Price Swings & Free Weekly Chart Analysis and Trade Guides - Newser
How Hepion Pharmaceuticals Inc. (336) stock reacts to Fed tighteningWeekly Trade Review & Entry Point Confirmation Signals - Newser
Is Hepion Pharmaceuticals Inc. (336) stock undervalued historicallyVolume Spike & Reliable Price Action Trade Plans - Newser
How Hepion Pharmaceuticals Inc. (336) stock behaves under inflation pressureMarket Risk Analysis & Weekly High Potential Stock Alerts - Newser
Hepion Pharmaceuticals Inc Stock (HEPA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.41%
Cap:
|
Volume (24h):